| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Child Behavior | 70 | 2021 | 865 | 11.590 |
Why?
|
| Netherlands | 250 | 2025 | 2277 | 11.310 |
Why?
|
| Prenatal Exposure Delayed Effects | 98 | 2024 | 2531 | 10.620 |
Why?
|
| Child Behavior Disorders | 48 | 2024 | 814 | 10.560 |
Why?
|
| Child Development | 71 | 2024 | 2327 | 7.060 |
Why?
|
| Parenting | 30 | 2024 | 709 | 6.140 |
Why?
|
| Mother-Child Relations | 27 | 2024 | 499 | 5.880 |
Why?
|
| Hydrocortisone | 37 | 2023 | 1827 | 5.780 |
Why?
|
| Mothers | 71 | 2024 | 2210 | 5.370 |
Why?
|
| Depression | 98 | 2024 | 8237 | 5.210 |
Why?
|
| Intelligence | 34 | 2024 | 923 | 4.810 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 46 | 2024 | 3719 | 4.580 |
Why?
|
| Pregnancy | 257 | 2025 | 30260 | 4.130 |
Why?
|
| Pregnancy Complications | 53 | 2024 | 2975 | 4.050 |
Why?
|
| Object Attachment | 16 | 2019 | 329 | 4.000 |
Why?
|
| Depressive Disorder | 43 | 2023 | 3714 | 3.990 |
Why?
|
| Bullying | 12 | 2024 | 234 | 3.860 |
Why?
|
| Child | 367 | 2025 | 80564 | 3.820 |
Why?
|
| Sleep | 40 | 2024 | 4813 | 3.640 |
Why?
|
| Thyroxine | 24 | 2023 | 672 | 3.570 |
Why?
|
| Fetal Development | 34 | 2024 | 777 | 3.550 |
Why?
|
| Maternal Behavior | 16 | 2019 | 306 | 3.390 |
Why?
|
| Mental Disorders | 48 | 2025 | 6853 | 3.350 |
Why?
|
| Brain | 104 | 2024 | 27171 | 3.320 |
Why?
|
| Anxiety Disorders | 33 | 2021 | 2737 | 3.250 |
Why?
|
| Female | 703 | 2025 | 396112 | 3.110 |
Why?
|
| Fathers | 17 | 2022 | 376 | 2.980 |
Why?
|
| Autistic Disorder | 20 | 2023 | 1239 | 2.970 |
Why?
|
| Circadian Rhythm | 22 | 2020 | 2592 | 2.910 |
Why?
|
| Child, Preschool | 208 | 2024 | 42500 | 2.910 |
Why?
|
| Prospective Studies | 223 | 2024 | 54802 | 2.870 |
Why?
|
| DNA Methylation | 33 | 2024 | 4424 | 2.780 |
Why?
|
| Cohort Studies | 222 | 2025 | 41649 | 2.730 |
Why?
|
| Grief | 7 | 2017 | 255 | 2.680 |
Why?
|
| Male | 566 | 2025 | 363698 | 2.630 |
Why?
|
| Genome-Wide Association Study | 105 | 2024 | 12807 | 2.570 |
Why?
|
| Fetal Blood | 30 | 2024 | 1369 | 2.560 |
Why?
|
| Humans | 838 | 2025 | 765968 | 2.550 |
Why?
|
| Pesticides | 11 | 2024 | 296 | 2.540 |
Why?
|
| Aggression | 20 | 2022 | 748 | 2.530 |
Why?
|
| Parent-Child Relations | 13 | 2024 | 774 | 2.520 |
Why?
|
| Cognition | 52 | 2024 | 7049 | 2.490 |
Why?
|
| Stress, Psychological | 32 | 2021 | 4533 | 2.430 |
Why?
|
| Maternal Exposure | 25 | 2024 | 1095 | 2.410 |
Why?
|
| Actigraphy | 15 | 2020 | 532 | 2.370 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 10 | 2020 | 307 | 2.350 |
Why?
|
| Longitudinal Studies | 104 | 2024 | 14751 | 2.350 |
Why?
|
| Polymorphism, Single Nucleotide | 88 | 2022 | 16047 | 2.320 |
Why?
|
| Executive Function | 20 | 2022 | 1391 | 2.320 |
Why?
|
| Infant | 148 | 2024 | 36386 | 2.300 |
Why?
|
| Iodine | 11 | 2021 | 288 | 2.240 |
Why?
|
| Infant Behavior | 10 | 2019 | 156 | 2.230 |
Why?
|
| Feeding Behavior | 23 | 2019 | 3212 | 2.140 |
Why?
|
| Thyrotropin | 22 | 2023 | 841 | 2.120 |
Why?
|
| Birth Weight | 27 | 2023 | 2121 | 2.020 |
Why?
|
| Breast Feeding | 13 | 2022 | 1364 | 2.020 |
Why?
|
| Temperament | 11 | 2015 | 299 | 1.920 |
Why?
|
| Crime Victims | 6 | 2024 | 348 | 1.920 |
Why?
|
| Gestational Age | 40 | 2024 | 3609 | 1.890 |
Why?
|
| Hostility | 4 | 2024 | 185 | 1.860 |
Why?
|
| Mortality | 17 | 2024 | 2904 | 1.860 |
Why?
|
| Saliva | 18 | 2017 | 851 | 1.730 |
Why?
|
| Infant, Newborn | 106 | 2024 | 26346 | 1.720 |
Why?
|
| Emotions | 20 | 2024 | 2763 | 1.710 |
Why?
|
| Schools | 13 | 2024 | 1492 | 1.710 |
Why?
|
| Vitamin D Deficiency | 12 | 2024 | 1348 | 1.710 |
Why?
|
| Child Abuse | 11 | 2021 | 1090 | 1.660 |
Why?
|
| Child of Impaired Parents | 8 | 2024 | 462 | 1.660 |
Why?
|
| Epigenesis, Genetic | 33 | 2024 | 3819 | 1.630 |
Why?
|
| Depressive Disorder, Major | 24 | 2024 | 4808 | 1.620 |
Why?
|
| Father-Child Relations | 4 | 2020 | 48 | 1.570 |
Why?
|
| Body Mass Index | 48 | 2024 | 13039 | 1.510 |
Why?
|
| Psychopathology | 11 | 2023 | 435 | 1.510 |
Why?
|
| Psychiatric Status Rating Scales | 39 | 2022 | 6014 | 1.500 |
Why?
|
| Affective Symptoms | 10 | 2019 | 417 | 1.470 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 10 | 2020 | 326 | 1.450 |
Why?
|
| Pituitary-Adrenal System | 13 | 2018 | 547 | 1.450 |
Why?
|
| Longevity | 15 | 2021 | 1087 | 1.440 |
Why?
|
| Behavioral Symptoms | 6 | 2020 | 187 | 1.430 |
Why?
|
| Aging | 25 | 2022 | 8731 | 1.410 |
Why?
|
| Peer Group | 8 | 2021 | 701 | 1.390 |
Why?
|
| Magnetic Resonance Imaging | 66 | 2024 | 36532 | 1.380 |
Why?
|
| Educational Status | 23 | 2024 | 2513 | 1.380 |
Why?
|
| Parents | 28 | 2024 | 3592 | 1.370 |
Why?
|
| Adult | 256 | 2024 | 223044 | 1.360 |
Why?
|
| Anxiety | 28 | 2024 | 4671 | 1.350 |
Why?
|
| Adolescent | 124 | 2025 | 88835 | 1.330 |
Why?
|
| Adoption | 5 | 2010 | 97 | 1.330 |
Why?
|
| Hair | 9 | 2023 | 508 | 1.320 |
Why?
|
| Thyroid Gland | 13 | 2023 | 1180 | 1.310 |
Why?
|
| Language Development | 8 | 2015 | 183 | 1.300 |
Why?
|
| Internal-External Control | 8 | 2024 | 347 | 1.290 |
Why?
|
| Population Surveillance | 23 | 2018 | 2590 | 1.270 |
Why?
|
| Folic Acid | 16 | 2020 | 1338 | 1.260 |
Why?
|
| Multifactorial Inheritance | 21 | 2024 | 1425 | 1.240 |
Why?
|
| Crying | 4 | 2023 | 37 | 1.230 |
Why?
|
| Mental Health | 19 | 2023 | 3278 | 1.230 |
Why?
|
| Genetic Predisposition to Disease | 57 | 2023 | 18071 | 1.220 |
Why?
|
| Motor Skills Disorders | 3 | 2018 | 89 | 1.180 |
Why?
|
| Language Development Disorders | 5 | 2016 | 194 | 1.180 |
Why?
|
| Cross-Sectional Studies | 67 | 2024 | 26318 | 1.170 |
Why?
|
| Risk Factors | 134 | 2024 | 74840 | 1.170 |
Why?
|
| Diffusion Tensor Imaging | 23 | 2024 | 2410 | 1.170 |
Why?
|
| Autonomic Nervous System | 4 | 2016 | 706 | 1.140 |
Why?
|
| Paternal Behavior | 3 | 2018 | 33 | 1.140 |
Why?
|
| Vitamin D | 16 | 2024 | 3272 | 1.120 |
Why?
|
| Health Status | 15 | 2019 | 4080 | 1.120 |
Why?
|
| Aged | 175 | 2024 | 171117 | 1.120 |
Why?
|
| Developmental Disabilities | 9 | 2018 | 1519 | 1.110 |
Why?
|
| Air Pollution | 15 | 2024 | 2380 | 1.110 |
Why?
|
| Dementia | 17 | 2022 | 2744 | 1.100 |
Why?
|
| Dyssomnias | 2 | 2018 | 28 | 1.100 |
Why?
|
| Thyroid Hormones | 7 | 2019 | 410 | 1.080 |
Why?
|
| Body Weight | 13 | 2024 | 4622 | 1.080 |
Why?
|
| Hypothyroidism | 8 | 2016 | 667 | 1.070 |
Why?
|
| Ultrasonography, Prenatal | 17 | 2021 | 1774 | 1.060 |
Why?
|
| Linear Models | 33 | 2023 | 5876 | 1.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 10 | 2017 | 1989 | 1.050 |
Why?
|
| Organophosphorus Compounds | 6 | 2024 | 209 | 1.050 |
Why?
|
| Juvenile Delinquency | 4 | 2021 | 115 | 1.040 |
Why?
|
| Happiness | 4 | 2017 | 173 | 1.030 |
Why?
|
| Child Rearing | 3 | 2019 | 74 | 1.030 |
Why?
|
| Self Report | 26 | 2022 | 3770 | 1.020 |
Why?
|
| Age Factors | 48 | 2021 | 18380 | 1.010 |
Why?
|
| Parturition | 5 | 2019 | 454 | 1.010 |
Why?
|
| Smoking | 29 | 2022 | 9081 | 1.010 |
Why?
|
| Antidepressive Agents | 14 | 2023 | 2897 | 1.000 |
Why?
|
| Geriatric Assessment | 10 | 2018 | 1429 | 0.990 |
Why?
|
| Pregnancy Trimester, First | 14 | 2019 | 919 | 0.990 |
Why?
|
| Head | 9 | 2018 | 925 | 0.980 |
Why?
|
| Hypothalamo-Hypophyseal System | 12 | 2018 | 697 | 0.970 |
Why?
|
| Personal Satisfaction | 7 | 2020 | 641 | 0.960 |
Why?
|
| Middle Aged | 174 | 2024 | 223009 | 0.960 |
Why?
|
| Psychotic Disorders | 11 | 2024 | 3270 | 0.950 |
Why?
|
| Self Disclosure | 4 | 2016 | 248 | 0.950 |
Why?
|
| Beds | 2 | 2015 | 48 | 0.930 |
Why?
|
| Environment | 10 | 2021 | 1114 | 0.930 |
Why?
|
| Pregnancy Trimester, Second | 11 | 2021 | 737 | 0.920 |
Why?
|
| Life Style | 10 | 2023 | 3926 | 0.920 |
Why?
|
| Family | 15 | 2024 | 3209 | 0.920 |
Why?
|
| C-Reactive Protein | 7 | 2024 | 3850 | 0.910 |
Why?
|
| Anti-Anxiety Agents | 3 | 2017 | 402 | 0.890 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 12 | 2021 | 395 | 0.890 |
Why?
|
| Air Pollutants | 10 | 2024 | 2923 | 0.880 |
Why?
|
| Aged, 80 and over | 87 | 2024 | 59489 | 0.880 |
Why?
|
| Cerebral Cortex | 11 | 2024 | 5767 | 0.880 |
Why?
|
| Trans Fatty Acids | 2 | 2022 | 155 | 0.860 |
Why?
|
| Loneliness | 4 | 2022 | 211 | 0.860 |
Why?
|
| Sexual Behavior | 3 | 2018 | 2193 | 0.850 |
Why?
|
| Folic Acid Deficiency | 4 | 2020 | 117 | 0.850 |
Why?
|
| Cognition Disorders | 12 | 2017 | 3967 | 0.830 |
Why?
|
| Phthalic Acids | 7 | 2024 | 484 | 0.830 |
Why?
|
| Vocabulary | 5 | 2023 | 165 | 0.820 |
Why?
|
| Bulimia Nervosa | 3 | 2014 | 208 | 0.820 |
Why?
|
| Intelligence Tests | 17 | 2020 | 504 | 0.820 |
Why?
|
| Neuropsychological Tests | 26 | 2021 | 7123 | 0.820 |
Why?
|
| Housing | 3 | 2024 | 683 | 0.810 |
Why?
|
| Family Therapy | 1 | 2024 | 214 | 0.810 |
Why?
|
| Cerebellum | 6 | 2023 | 1518 | 0.810 |
Why?
|
| Social Behavior | 10 | 2021 | 1146 | 0.810 |
Why?
|
| Schizophrenia | 16 | 2022 | 6972 | 0.800 |
Why?
|
| Bipolar Disorder | 11 | 2022 | 5138 | 0.790 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 6 | 2023 | 1090 | 0.780 |
Why?
|
| Iodide Peroxidase | 10 | 2019 | 297 | 0.780 |
Why?
|
| Genotype | 38 | 2020 | 13024 | 0.770 |
Why?
|
| Hallucinations | 5 | 2022 | 373 | 0.760 |
Why?
|
| Creatinine | 5 | 2021 | 1915 | 0.760 |
Why?
|
| Deficiency Diseases | 2 | 2021 | 75 | 0.750 |
Why?
|
| Family Conflict | 3 | 2024 | 95 | 0.750 |
Why?
|
| Receptors, Dopamine D4 | 7 | 2018 | 168 | 0.740 |
Why?
|
| Thalamus | 4 | 2021 | 1048 | 0.740 |
Why?
|
| Fatty Acids, Omega-6 | 7 | 2017 | 226 | 0.740 |
Why?
|
| Adiposity | 7 | 2023 | 1890 | 0.740 |
Why?
|
| Social Class | 8 | 2019 | 2007 | 0.730 |
Why?
|
| Amygdala | 8 | 2024 | 1377 | 0.730 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2021 | 541 | 0.720 |
Why?
|
| Socioeconomic Factors | 34 | 2018 | 7838 | 0.720 |
Why?
|
| Obesity | 22 | 2023 | 13076 | 0.720 |
Why?
|
| Thyroid Diseases | 6 | 2019 | 388 | 0.710 |
Why?
|
| Fetus | 12 | 2022 | 1870 | 0.710 |
Why?
|
| Psychometrics | 13 | 2022 | 3062 | 0.700 |
Why?
|
| Interpersonal Relations | 6 | 2015 | 1432 | 0.700 |
Why?
|
| Receptors, Glucocorticoid | 6 | 2020 | 308 | 0.700 |
Why?
|
| Depression, Postpartum | 8 | 2022 | 360 | 0.700 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2012 | 251 | 0.690 |
Why?
|
| Body Composition | 9 | 2021 | 2439 | 0.690 |
Why?
|
| Adolescent Development | 1 | 2023 | 275 | 0.690 |
Why?
|
| Sleep Deprivation | 5 | 2016 | 845 | 0.690 |
Why?
|
| Affect | 5 | 2017 | 1500 | 0.680 |
Why?
|
| Emotional Intelligence | 4 | 2015 | 135 | 0.680 |
Why?
|
| Follow-Up Studies | 49 | 2022 | 39193 | 0.680 |
Why?
|
| Premature Birth | 13 | 2022 | 1829 | 0.670 |
Why?
|
| Cortisone | 3 | 2018 | 90 | 0.670 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2020 | 83 | 0.670 |
Why?
|
| Life Expectancy | 8 | 2017 | 1247 | 0.670 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2021 | 538 | 0.670 |
Why?
|
| Hair Color | 2 | 2017 | 132 | 0.660 |
Why?
|
| Social Isolation | 2 | 2023 | 366 | 0.660 |
Why?
|
| Tacrolimus Binding Proteins | 4 | 2017 | 199 | 0.650 |
Why?
|
| Acculturation | 2 | 2018 | 178 | 0.650 |
Why?
|
| Phlebotomy | 2 | 2011 | 138 | 0.640 |
Why?
|
| Attention | 11 | 2021 | 2419 | 0.640 |
Why?
|
| Pregnancy Outcome | 11 | 2021 | 2966 | 0.640 |
Why?
|
| Cerebrovascular Disorders | 5 | 2022 | 1470 | 0.640 |
Why?
|
| Environmental Pollutants | 6 | 2024 | 1290 | 0.640 |
Why?
|
| Divorce | 2 | 2019 | 78 | 0.640 |
Why?
|
| Melatonin | 2 | 2024 | 674 | 0.640 |
Why?
|
| Contraceptive Agents | 1 | 2020 | 147 | 0.630 |
Why?
|
| Child Development Disorders, Pervasive | 5 | 2017 | 597 | 0.630 |
Why?
|
| Overweight | 9 | 2021 | 2444 | 0.630 |
Why?
|
| Family Characteristics | 10 | 2022 | 1001 | 0.620 |
Why?
|
| Parasomnias | 1 | 2018 | 27 | 0.620 |
Why?
|
| Young Adult | 72 | 2024 | 59889 | 0.610 |
Why?
|
| Students | 3 | 2024 | 1734 | 0.610 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 3 | 2021 | 160 | 0.610 |
Why?
|
| Psychiatry | 3 | 2023 | 1714 | 0.600 |
Why?
|
| Interview, Psychological | 4 | 2020 | 812 | 0.600 |
Why?
|
| Heart Rate | 7 | 2017 | 4204 | 0.600 |
Why?
|
| Cholesterol | 7 | 2023 | 2898 | 0.600 |
Why?
|
| Pregnancy Trimester, Third | 7 | 2018 | 587 | 0.600 |
Why?
|
| Facial Expression | 4 | 2023 | 516 | 0.600 |
Why?
|
| Comorbidity | 24 | 2023 | 10563 | 0.600 |
Why?
|
| Noise, Transportation | 3 | 2023 | 60 | 0.600 |
Why?
|
| Epidemiologic Research Design | 8 | 2017 | 368 | 0.590 |
Why?
|
| Dexamethasone | 2 | 2016 | 1963 | 0.590 |
Why?
|
| Hippocampus | 6 | 2021 | 3775 | 0.590 |
Why?
|
| Asphyxia Neonatorum | 1 | 2019 | 112 | 0.580 |
Why?
|
| Logistic Models | 23 | 2024 | 13266 | 0.580 |
Why?
|
| Cerebral Ventricles | 3 | 2012 | 549 | 0.580 |
Why?
|
| Pigments, Biological | 1 | 2017 | 52 | 0.580 |
Why?
|
| Sex Characteristics | 14 | 2024 | 2643 | 0.580 |
Why?
|
| CpG Islands | 10 | 2024 | 1207 | 0.580 |
Why?
|
| Independent Living | 3 | 2018 | 585 | 0.570 |
Why?
|
| Prevalence | 29 | 2022 | 15842 | 0.570 |
Why?
|
| Infant, Premature | 6 | 2022 | 2122 | 0.570 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2024 | 2187 | 0.570 |
Why?
|
| Motor Skills | 3 | 2020 | 516 | 0.570 |
Why?
|
| Cardiovascular Diseases | 23 | 2024 | 15652 | 0.570 |
Why?
|
| Community Health Planning | 10 | 2018 | 164 | 0.560 |
Why?
|
| Pyramidal Tracts | 1 | 2019 | 249 | 0.560 |
Why?
|
| Personality Assessment | 5 | 2015 | 646 | 0.560 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2017 | 228 | 0.560 |
Why?
|
| Poverty | 5 | 2023 | 2714 | 0.560 |
Why?
|
| Risk | 22 | 2017 | 9591 | 0.560 |
Why?
|
| Memory, Short-Term | 6 | 2023 | 1003 | 0.560 |
Why?
|
| Genetic Loci | 12 | 2022 | 2631 | 0.560 |
Why?
|
| Life Change Events | 5 | 2023 | 954 | 0.550 |
Why?
|
| Brain Mapping | 8 | 2022 | 6601 | 0.550 |
Why?
|
| Muscle Tonus | 1 | 2017 | 82 | 0.540 |
Why?
|
| Pigmentation | 1 | 2017 | 143 | 0.540 |
Why?
|
| Psychomotor Performance | 7 | 2017 | 1881 | 0.540 |
Why?
|
| Motor Activity | 4 | 2021 | 2704 | 0.540 |
Why?
|
| Environmental Exposure | 20 | 2025 | 4544 | 0.540 |
Why?
|
| Crowding | 2 | 2014 | 142 | 0.530 |
Why?
|
| Asthma | 8 | 2024 | 6270 | 0.530 |
Why?
|
| Antisocial Personality Disorder | 5 | 2021 | 223 | 0.530 |
Why?
|
| Brain Waves | 1 | 2020 | 417 | 0.530 |
Why?
|
| Rest | 3 | 2020 | 942 | 0.520 |
Why?
|
| Residence Characteristics | 7 | 2015 | 2116 | 0.520 |
Why?
|
| Infant, Small for Gestational Age | 7 | 2021 | 469 | 0.520 |
Why?
|
| Middle Cerebral Artery | 2 | 2021 | 268 | 0.520 |
Why?
|
| Genetic Pleiotropy | 2 | 2018 | 182 | 0.520 |
Why?
|
| Maternal Age | 8 | 2023 | 804 | 0.520 |
Why?
|
| Fatty Acids, Omega-3 | 9 | 2019 | 1396 | 0.510 |
Why?
|
| Maternal Health Services | 3 | 2021 | 472 | 0.510 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2010 | 300 | 0.510 |
Why?
|
| Adolescent Behavior | 3 | 2021 | 1185 | 0.510 |
Why?
|
| Anorexia Nervosa | 3 | 2014 | 1328 | 0.510 |
Why?
|
| Phenols | 5 | 2024 | 522 | 0.510 |
Why?
|
| Particulate Matter | 14 | 2024 | 2624 | 0.510 |
Why?
|
| Sex Factors | 25 | 2024 | 10603 | 0.510 |
Why?
|
| Corpus Callosum | 4 | 2019 | 751 | 0.500 |
Why?
|
| Marital Status | 2 | 2017 | 426 | 0.500 |
Why?
|
| Emigration and Immigration | 2 | 2009 | 405 | 0.500 |
Why?
|
| Infant Food | 2 | 2017 | 139 | 0.500 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 261 | 0.490 |
Why?
|
| Temporal Lobe | 4 | 2024 | 1714 | 0.490 |
Why?
|
| Muscle Hypotonia | 1 | 2017 | 167 | 0.490 |
Why?
|
| Cephalometry | 6 | 2018 | 380 | 0.490 |
Why?
|
| Iron-Binding Proteins | 5 | 2019 | 83 | 0.490 |
Why?
|
| Seasons | 4 | 2018 | 1524 | 0.490 |
Why?
|
| Neurobiology | 2 | 2020 | 135 | 0.490 |
Why?
|
| Placental Insufficiency | 2 | 2021 | 50 | 0.490 |
Why?
|
| Food Preferences | 5 | 2017 | 397 | 0.480 |
Why?
|
| Activity Cycles | 1 | 2015 | 47 | 0.480 |
Why?
|
| Adjustment Disorders | 2 | 2015 | 68 | 0.480 |
Why?
|
| Mendelian Randomization Analysis | 9 | 2023 | 1044 | 0.480 |
Why?
|
| Exercise | 8 | 2023 | 5937 | 0.480 |
Why?
|
| Health Surveys | 9 | 2020 | 4056 | 0.480 |
Why?
|
| Inflammation | 5 | 2024 | 10850 | 0.480 |
Why?
|
| Sex Offenses | 1 | 2019 | 356 | 0.470 |
Why?
|
| Research Design | 14 | 2023 | 6209 | 0.470 |
Why?
|
| Achievement | 1 | 2016 | 287 | 0.470 |
Why?
|
| Bedding and Linens | 1 | 2014 | 41 | 0.470 |
Why?
|
| Frontal Lobe | 3 | 2018 | 1410 | 0.470 |
Why?
|
| Diet | 10 | 2022 | 8086 | 0.470 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2015 | 587 | 0.460 |
Why?
|
| Infant Care | 1 | 2015 | 181 | 0.450 |
Why?
|
| Reactive Attachment Disorder | 2 | 2011 | 42 | 0.450 |
Why?
|
| Phenotype | 29 | 2023 | 16721 | 0.450 |
Why?
|
| Caregivers | 4 | 2024 | 2307 | 0.450 |
Why?
|
| Waist Circumference | 5 | 2019 | 932 | 0.440 |
Why?
|
| Echoencephalography | 3 | 2012 | 133 | 0.440 |
Why?
|
| Child Language | 2 | 2012 | 62 | 0.440 |
Why?
|
| Checklist | 7 | 2017 | 848 | 0.440 |
Why?
|
| Fear | 6 | 2017 | 1499 | 0.440 |
Why?
|
| Faculty | 2 | 2014 | 384 | 0.440 |
Why?
|
| Dietary Supplements | 8 | 2020 | 3425 | 0.440 |
Why?
|
| Family Relations | 2 | 2013 | 318 | 0.440 |
Why?
|
| Punishment | 1 | 2014 | 95 | 0.430 |
Why?
|
| Time Factors | 28 | 2024 | 40065 | 0.430 |
Why?
|
| Nerve Net | 4 | 2023 | 2309 | 0.430 |
Why?
|
| Genetic Association Studies | 8 | 2021 | 2741 | 0.430 |
Why?
|
| Fetal Weight | 5 | 2016 | 90 | 0.430 |
Why?
|
| Eating | 4 | 2017 | 1540 | 0.420 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2017 | 352 | 0.420 |
Why?
|
| Sweden | 6 | 2022 | 1381 | 0.420 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 5 | 2014 | 276 | 0.410 |
Why?
|
| Pregnancy, Unplanned | 1 | 2013 | 86 | 0.410 |
Why?
|
| Sleep, REM | 2 | 2015 | 588 | 0.410 |
Why?
|
| Culture | 3 | 2017 | 622 | 0.410 |
Why?
|
| Infant Welfare | 2 | 2012 | 78 | 0.410 |
Why?
|
| Benzodiazepines | 2 | 2017 | 1136 | 0.400 |
Why?
|
| Infant, Postmature | 1 | 2012 | 11 | 0.400 |
Why?
|
| Anthropometry | 7 | 2018 | 1338 | 0.400 |
Why?
|
| Quantitative Trait Loci | 7 | 2021 | 2140 | 0.400 |
Why?
|
| Nutritional Status | 6 | 2017 | 1620 | 0.400 |
Why?
|
| Polymorphism, Genetic | 12 | 2019 | 4247 | 0.400 |
Why?
|
| Basal Ganglia | 3 | 2018 | 549 | 0.400 |
Why?
|
| Cholesterol, HDL | 7 | 2023 | 1811 | 0.390 |
Why?
|
| Gene Frequency | 12 | 2018 | 3624 | 0.390 |
Why?
|
| Wakefulness | 4 | 2020 | 1282 | 0.390 |
Why?
|
| Homozygote | 4 | 2016 | 1775 | 0.390 |
Why?
|
| Thyroid Function Tests | 9 | 2023 | 293 | 0.390 |
Why?
|
| Expressed Emotion | 1 | 2012 | 93 | 0.390 |
Why?
|
| Cause of Death | 5 | 2024 | 3708 | 0.390 |
Why?
|
| Pregnancy Trimesters | 3 | 2019 | 198 | 0.390 |
Why?
|
| Carotid Artery Diseases | 3 | 2010 | 874 | 0.380 |
Why?
|
| Hypnotics and Sedatives | 2 | 2017 | 1191 | 0.380 |
Why?
|
| Epidemiologic Methods | 4 | 2010 | 1326 | 0.370 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 2415 | 0.370 |
Why?
|
| Autoantigens | 5 | 2019 | 883 | 0.370 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 2022 | 1484 | 0.370 |
Why?
|
| Blood Flow Velocity | 3 | 2021 | 1381 | 0.370 |
Why?
|
| Monoamine Oxidase | 2 | 2009 | 179 | 0.370 |
Why?
|
| Models, Statistical | 4 | 2022 | 5089 | 0.360 |
Why?
|
| Secretory Pathway | 1 | 2011 | 53 | 0.360 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 2045 | 0.360 |
Why?
|
| Glucocorticoids | 2 | 2023 | 2132 | 0.360 |
Why?
|
| Fruit | 2 | 2018 | 1166 | 0.350 |
Why?
|
| Polysomnography | 4 | 2019 | 1859 | 0.350 |
Why?
|
| Survival | 1 | 2011 | 160 | 0.350 |
Why?
|
| Individuality | 2 | 2022 | 303 | 0.350 |
Why?
|
| Regression Analysis | 9 | 2018 | 6322 | 0.340 |
Why?
|
| Benzhydryl Compounds | 5 | 2024 | 939 | 0.340 |
Why?
|
| Odds Ratio | 13 | 2022 | 9649 | 0.340 |
Why?
|
| Proportional Hazards Models | 16 | 2024 | 12509 | 0.340 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2011 | 167 | 0.340 |
Why?
|
| Atherosclerosis | 5 | 2023 | 3424 | 0.340 |
Why?
|
| Functional Laterality | 6 | 2021 | 2243 | 0.340 |
Why?
|
| Homocysteine | 5 | 2016 | 638 | 0.340 |
Why?
|
| Ischemic Attack, Transient | 2 | 2016 | 870 | 0.340 |
Why?
|
| Coffee | 4 | 2016 | 593 | 0.330 |
Why?
|
| Statistics as Topic | 6 | 2017 | 2352 | 0.330 |
Why?
|
| Area Under Curve | 7 | 2017 | 1638 | 0.330 |
Why?
|
| Receptors, Oxytocin | 3 | 2016 | 71 | 0.330 |
Why?
|
| Stroke | 12 | 2022 | 9747 | 0.330 |
Why?
|
| Postpartum Period | 4 | 2019 | 1205 | 0.320 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1053 | 0.320 |
Why?
|
| Electromagnetic Fields | 2 | 2021 | 290 | 0.320 |
Why?
|
| Retinal Vessels | 2 | 2017 | 863 | 0.320 |
Why?
|
| Human Development | 3 | 2019 | 122 | 0.320 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2013 | 501 | 0.310 |
Why?
|
| Photoperiod | 1 | 2009 | 141 | 0.310 |
Why?
|
| Behavior | 3 | 2019 | 535 | 0.310 |
Why?
|
| Child Psychiatry | 1 | 2011 | 233 | 0.310 |
Why?
|
| Mood Disorders | 3 | 2013 | 1128 | 0.310 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2016 | 119 | 0.310 |
Why?
|
| Registries | 6 | 2017 | 8297 | 0.300 |
Why?
|
| Maternal-Fetal Exchange | 4 | 2015 | 453 | 0.300 |
Why?
|
| Transcortin | 2 | 2021 | 12 | 0.300 |
Why?
|
| Quality of Life | 11 | 2018 | 13462 | 0.300 |
Why?
|
| Periodicity | 1 | 2009 | 345 | 0.300 |
Why?
|
| Fatty Acids | 4 | 2019 | 1806 | 0.300 |
Why?
|
| Adult Children | 1 | 2009 | 104 | 0.300 |
Why?
|
| Case-Control Studies | 25 | 2021 | 22223 | 0.300 |
Why?
|
| Autoimmunity | 2 | 2017 | 1354 | 0.300 |
Why?
|
| Psychomotor Disorders | 1 | 2009 | 149 | 0.290 |
Why?
|
| Language | 4 | 2023 | 1550 | 0.290 |
Why?
|
| Prenatal Diagnosis | 3 | 2015 | 1268 | 0.290 |
Why?
|
| Nitrogen Dioxide | 5 | 2022 | 538 | 0.290 |
Why?
|
| Chronic Disease | 9 | 2017 | 9347 | 0.290 |
Why?
|
| Psychophysiologic Disorders | 1 | 2009 | 222 | 0.290 |
Why?
|
| Severity of Illness Index | 12 | 2021 | 15880 | 0.280 |
Why?
|
| Altruism | 2 | 2021 | 211 | 0.280 |
Why?
|
| Prenatal Care | 6 | 2023 | 1160 | 0.280 |
Why?
|
| Learning | 3 | 2014 | 1755 | 0.280 |
Why?
|
| Prefrontal Cortex | 5 | 2024 | 2224 | 0.280 |
Why?
|
| Placenta | 6 | 2023 | 1728 | 0.280 |
Why?
|
| Neural Pathways | 8 | 2024 | 3085 | 0.280 |
Why?
|
| Population Dynamics | 3 | 2015 | 314 | 0.280 |
Why?
|
| Models, Psychological | 4 | 2019 | 824 | 0.280 |
Why?
|
| Risk-Taking | 2 | 2024 | 1021 | 0.280 |
Why?
|
| Predictive Value of Tests | 11 | 2021 | 15398 | 0.280 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2021 | 168 | 0.280 |
Why?
|
| Hypercholesterolemia | 2 | 2011 | 1149 | 0.280 |
Why?
|
| Organ Size | 9 | 2018 | 2260 | 0.270 |
Why?
|
| Sequence Deletion | 1 | 2011 | 1495 | 0.270 |
Why?
|
| Pregnancy Proteins | 4 | 2016 | 225 | 0.270 |
Why?
|
| Parity | 4 | 2023 | 931 | 0.270 |
Why?
|
| Aryldialkylphosphatase | 2 | 2024 | 64 | 0.270 |
Why?
|
| Incidence | 22 | 2018 | 21480 | 0.270 |
Why?
|
| Body Height | 4 | 2015 | 1562 | 0.270 |
Why?
|
| Autoantibodies | 6 | 2019 | 2113 | 0.270 |
Why?
|
| Nervous System | 1 | 2010 | 542 | 0.270 |
Why?
|
| Alcohol Drinking | 9 | 2023 | 4040 | 0.270 |
Why?
|
| Genetic Markers | 2 | 2013 | 2601 | 0.270 |
Why?
|
| Respiratory Sounds | 3 | 2024 | 705 | 0.270 |
Why?
|
| Income | 5 | 2022 | 1874 | 0.260 |
Why?
|
| Irritable Mood | 2 | 2018 | 196 | 0.260 |
Why?
|
| Speech | 4 | 2022 | 555 | 0.260 |
Why?
|
| Acetaminophen | 2 | 2021 | 547 | 0.260 |
Why?
|
| Nitrogen Oxides | 4 | 2020 | 128 | 0.260 |
Why?
|
| Data Collection | 5 | 2022 | 3318 | 0.260 |
Why?
|
| Europe | 10 | 2025 | 3423 | 0.260 |
Why?
|
| Epidemiologic Studies | 1 | 2009 | 677 | 0.260 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2011 | 827 | 0.260 |
Why?
|
| Television | 3 | 2014 | 409 | 0.260 |
Why?
|
| Weight Gain | 2 | 2015 | 2355 | 0.260 |
Why?
|
| Fertility | 1 | 2011 | 768 | 0.260 |
Why?
|
| Genetic Variation | 12 | 2020 | 6610 | 0.260 |
Why?
|
| Writing | 1 | 2008 | 199 | 0.260 |
Why?
|
| Smoking Cessation | 5 | 2011 | 2084 | 0.250 |
Why?
|
| Hypertension | 6 | 2018 | 8626 | 0.250 |
Why?
|
| Self-Injurious Behavior | 2 | 2023 | 570 | 0.250 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 1325 | 0.240 |
Why?
|
| alpha 1-Antichymotrypsin | 2 | 2015 | 18 | 0.240 |
Why?
|
| Cannabis | 4 | 2015 | 446 | 0.240 |
Why?
|
| Deception | 2 | 2017 | 99 | 0.240 |
Why?
|
| Mass Screening | 6 | 2021 | 5446 | 0.240 |
Why?
|
| Reference Values | 11 | 2018 | 4908 | 0.240 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1509 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2016 | 561 | 0.230 |
Why?
|
| Hyperkinesis | 2 | 2015 | 88 | 0.230 |
Why?
|
| Monitoring, Ambulatory | 1 | 2008 | 357 | 0.230 |
Why?
|
| Energy Intake | 3 | 2017 | 2141 | 0.230 |
Why?
|
| Infant, Low Birth Weight | 5 | 2021 | 871 | 0.230 |
Why?
|
| Milk, Human | 2 | 2022 | 490 | 0.230 |
Why?
|
| Cognitive Reserve | 2 | 2015 | 92 | 0.230 |
Why?
|
| Alleles | 10 | 2019 | 6897 | 0.230 |
Why?
|
| Apgar Score | 3 | 2021 | 124 | 0.220 |
Why?
|
| Emigrants and Immigrants | 1 | 2010 | 549 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2019 | 12240 | 0.220 |
Why?
|
| Neuropeptides | 1 | 2009 | 951 | 0.220 |
Why?
|
| Chorionic Gonadotropin | 2 | 2017 | 457 | 0.220 |
Why?
|
| Abdomen | 1 | 2010 | 1134 | 0.220 |
Why?
|
| Personality Development | 2 | 2016 | 242 | 0.220 |
Why?
|
| Vitamin B 12 | 4 | 2016 | 532 | 0.210 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2017 | 346 | 0.210 |
Why?
|
| Hyperthyroidism | 3 | 2014 | 294 | 0.210 |
Why?
|
| Glucose | 5 | 2023 | 4335 | 0.210 |
Why?
|
| Fetal Diseases | 1 | 2009 | 914 | 0.210 |
Why?
|
| Physical Examination | 5 | 2017 | 1266 | 0.210 |
Why?
|
| Anisotropy | 4 | 2020 | 1282 | 0.210 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 11499 | 0.210 |
Why?
|
| Spain | 5 | 2025 | 483 | 0.210 |
Why?
|
| Arousal | 1 | 2009 | 1171 | 0.210 |
Why?
|
| Sexual Partners | 2 | 2018 | 804 | 0.210 |
Why?
|
| Survival Analysis | 5 | 2019 | 10070 | 0.210 |
Why?
|
| Genome, Human | 6 | 2020 | 4448 | 0.210 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2024 | 120 | 0.210 |
Why?
|
| Lateral Ventricles | 2 | 2018 | 142 | 0.210 |
Why?
|
| Vitamin E Deficiency | 1 | 2002 | 30 | 0.200 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 3076 | 0.200 |
Why?
|
| Blood Pressure | 11 | 2023 | 8532 | 0.200 |
Why?
|
| Reproducibility of Results | 9 | 2017 | 20124 | 0.200 |
Why?
|
| Prediabetic State | 2 | 2021 | 548 | 0.200 |
Why?
|
| Rural Population | 3 | 2024 | 2317 | 0.200 |
Why?
|
| Insulin | 4 | 2023 | 6599 | 0.200 |
Why?
|
| Violence | 3 | 2023 | 935 | 0.200 |
Why?
|
| Growth Disorders | 3 | 2013 | 633 | 0.200 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 117 | 0.200 |
Why?
|
| Ultrasonography | 5 | 2018 | 5993 | 0.200 |
Why?
|
| Pregnant Women | 4 | 2021 | 575 | 0.190 |
Why?
|
| Microvessels | 2 | 2017 | 591 | 0.190 |
Why?
|
| Heterosexuality | 1 | 2024 | 308 | 0.190 |
Why?
|
| Frail Elderly | 3 | 2016 | 785 | 0.190 |
Why?
|
| Pain | 3 | 2017 | 5077 | 0.190 |
Why?
|
| Proteins | 2 | 2015 | 5995 | 0.190 |
Why?
|
| Haplotypes | 4 | 2019 | 2728 | 0.190 |
Why?
|
| Estrogen Receptor alpha | 1 | 2005 | 578 | 0.180 |
Why?
|
| Marijuana Abuse | 3 | 2010 | 411 | 0.180 |
Why?
|
| Risk Assessment | 14 | 2021 | 24282 | 0.180 |
Why?
|
| Hospitalization | 2 | 2021 | 10808 | 0.180 |
Why?
|
| Conduct Disorder | 2 | 2017 | 246 | 0.180 |
Why?
|
| Principal Component Analysis | 4 | 2018 | 951 | 0.180 |
Why?
|
| Age of Onset | 4 | 2019 | 3344 | 0.180 |
Why?
|
| Self Concept | 3 | 2021 | 1037 | 0.180 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2021 | 366 | 0.180 |
Why?
|
| Pandemics | 1 | 2021 | 8703 | 0.180 |
Why?
|
| Domestic Violence | 2 | 2021 | 182 | 0.180 |
Why?
|
| Spouses | 2 | 2015 | 288 | 0.180 |
Why?
|
| Thyroiditis, Autoimmune | 2 | 2018 | 101 | 0.180 |
Why?
|
| Fatigue | 3 | 2024 | 1549 | 0.170 |
Why?
|
| Stuttering | 1 | 2020 | 24 | 0.170 |
Why?
|
| Seizures, Febrile | 2 | 2012 | 109 | 0.170 |
Why?
|
| Synaptic Transmission | 3 | 2016 | 1175 | 0.170 |
Why?
|
| Bereavement | 1 | 2024 | 308 | 0.170 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2019 | 355 | 0.170 |
Why?
|
| Sleep Stages | 2 | 2002 | 698 | 0.170 |
Why?
|
| Qualitative Research | 2 | 2024 | 3139 | 0.170 |
Why?
|
| Somatoform Disorders | 2 | 2016 | 425 | 0.170 |
Why?
|
| Metabolomics | 2 | 2019 | 1668 | 0.170 |
Why?
|
| Guideline Adherence | 2 | 2017 | 2243 | 0.170 |
Why?
|
| Public Housing | 1 | 2021 | 140 | 0.160 |
Why?
|
| Menopause | 2 | 2022 | 1659 | 0.160 |
Why?
|
| Minority Groups | 4 | 2021 | 1207 | 0.160 |
Why?
|
| Genetics, Population | 4 | 2016 | 943 | 0.160 |
Why?
|
| Genetics, Behavioral | 2 | 2019 | 52 | 0.160 |
Why?
|
| Heart Diseases | 3 | 2019 | 2821 | 0.160 |
Why?
|
| Docosahexaenoic Acids | 3 | 2019 | 916 | 0.160 |
Why?
|
| Amyloid beta-Peptides | 1 | 2013 | 3896 | 0.160 |
Why?
|
| Body Fluid Compartments | 1 | 2019 | 48 | 0.160 |
Why?
|
| Norepinephrine | 1 | 2002 | 900 | 0.160 |
Why?
|
| Fetal Growth Retardation | 5 | 2021 | 591 | 0.160 |
Why?
|
| Occipital Lobe | 1 | 2021 | 376 | 0.160 |
Why?
|
| Septum Pellucidum | 1 | 2019 | 55 | 0.160 |
Why?
|
| Ferritins | 1 | 2021 | 600 | 0.160 |
Why?
|
| Infant Mortality | 2 | 2022 | 751 | 0.160 |
Why?
|
| Public Health | 2 | 2023 | 2680 | 0.150 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 102 | 0.150 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2019 | 88 | 0.150 |
Why?
|
| Reading | 1 | 2022 | 539 | 0.150 |
Why?
|
| Lipids | 3 | 2019 | 3315 | 0.150 |
Why?
|
| Apolipoproteins E | 3 | 2014 | 1458 | 0.150 |
Why?
|
| Bone Density | 4 | 2017 | 3491 | 0.150 |
Why?
|
| Sunlight | 1 | 2020 | 337 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 4 | 2016 | 1370 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2024 | 497 | 0.150 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 2018 | 24 | 0.150 |
Why?
|
| Diet Records | 2 | 2017 | 425 | 0.150 |
Why?
|
| Constipation | 2 | 2014 | 568 | 0.150 |
Why?
|
| Epinephrine | 1 | 2002 | 783 | 0.150 |
Why?
|
| Coffea | 2 | 2015 | 22 | 0.150 |
Why?
|
| Retinal Neurons | 1 | 2018 | 67 | 0.150 |
Why?
|
| Arthralgia | 2 | 2015 | 459 | 0.150 |
Why?
|
| Platelet Activation | 1 | 2021 | 645 | 0.150 |
Why?
|
| Parietal Lobe | 3 | 2020 | 858 | 0.150 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 190 | 0.150 |
Why?
|
| Ibuprofen | 1 | 2019 | 228 | 0.150 |
Why?
|
| Orthodontics, Corrective | 1 | 2018 | 76 | 0.150 |
Why?
|
| Causality | 4 | 2020 | 1248 | 0.150 |
Why?
|
| Triglycerides | 4 | 2023 | 2441 | 0.150 |
Why?
|
| Memory Disorders | 2 | 2015 | 1194 | 0.150 |
Why?
|
| Pharmacogenetics | 2 | 2015 | 682 | 0.150 |
Why?
|
| Health Status Disparities | 3 | 2018 | 1880 | 0.140 |
Why?
|
| Statistics, Nonparametric | 3 | 2014 | 2844 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 2674 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4392 | 0.140 |
Why?
|
| Dreams | 1 | 2018 | 144 | 0.140 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2018 | 142 | 0.140 |
Why?
|
| Malocclusion | 1 | 2018 | 130 | 0.140 |
Why?
|
| Impulsive Behavior | 2 | 2022 | 344 | 0.140 |
Why?
|
| Megakaryocytes | 1 | 2021 | 557 | 0.140 |
Why?
|
| Body Size | 2 | 2017 | 459 | 0.140 |
Why?
|
| Substance-Related Disorders | 4 | 2021 | 4416 | 0.140 |
Why?
|
| Environmental Monitoring | 3 | 2014 | 1470 | 0.140 |
Why?
|
| Minisatellite Repeats | 2 | 2014 | 162 | 0.140 |
Why?
|
| Feeding Methods | 1 | 2017 | 35 | 0.140 |
Why?
|
| Risk Management | 1 | 2020 | 559 | 0.140 |
Why?
|
| DNA | 5 | 2021 | 7202 | 0.140 |
Why?
|
| Vehicle Emissions | 1 | 2022 | 651 | 0.140 |
Why?
|
| Survival Rate | 2 | 2013 | 12795 | 0.140 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2016 | 19 | 0.140 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2017 | 42 | 0.140 |
Why?
|
| Linkage Disequilibrium | 6 | 2019 | 1997 | 0.140 |
Why?
|
| Feedback, Physiological | 2 | 2016 | 480 | 0.140 |
Why?
|
| Mannosidases | 1 | 2016 | 21 | 0.130 |
Why?
|
| Levonorgestrel | 1 | 2017 | 76 | 0.130 |
Why?
|
| Research | 1 | 2005 | 1975 | 0.130 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 869 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2012 | 276 | 0.130 |
Why?
|
| Observer Variation | 2 | 2013 | 2615 | 0.130 |
Why?
|
| Telomere | 1 | 2022 | 943 | 0.130 |
Why?
|
| Touch | 1 | 2018 | 309 | 0.130 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2016 | 31 | 0.130 |
Why?
|
| Lung Diseases | 2 | 2018 | 1940 | 0.130 |
Why?
|
| Electrocardiography | 4 | 2016 | 6404 | 0.130 |
Why?
|
| United States | 9 | 2024 | 72903 | 0.130 |
Why?
|
| Denmark | 2 | 2018 | 774 | 0.130 |
Why?
|
| Metabolism | 1 | 2017 | 193 | 0.130 |
Why?
|
| Dental Health Surveys | 1 | 2015 | 39 | 0.130 |
Why?
|
| Cesarean Section | 1 | 2024 | 1431 | 0.130 |
Why?
|
| Health Behavior | 3 | 2019 | 2650 | 0.120 |
Why?
|
| Inhalation Exposure | 1 | 2018 | 432 | 0.120 |
Why?
|
| Antigens, Nuclear | 1 | 2016 | 182 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.120 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2017 | 292 | 0.120 |
Why?
|
| Forecasting | 3 | 2023 | 2936 | 0.120 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2017 | 216 | 0.120 |
Why?
|
| Fishes | 2 | 2016 | 606 | 0.120 |
Why?
|
| Unemployment | 1 | 2017 | 211 | 0.120 |
Why?
|
| Meditation | 1 | 2018 | 256 | 0.120 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 11888 | 0.120 |
Why?
|
| Language Tests | 1 | 2015 | 191 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2021 | 8733 | 0.120 |
Why?
|
| India | 1 | 2022 | 2334 | 0.120 |
Why?
|
| Epilepsy | 2 | 2010 | 3320 | 0.120 |
Why?
|
| Biological Specimen Banks | 3 | 2021 | 786 | 0.120 |
Why?
|
| Neurosciences | 2 | 2017 | 385 | 0.120 |
Why?
|
| Time | 1 | 2017 | 550 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 1102 | 0.120 |
Why?
|
| Health | 2 | 2019 | 397 | 0.120 |
Why?
|
| Dermatitis, Atopic | 2 | 2013 | 729 | 0.120 |
Why?
|
| Australia | 4 | 2022 | 1258 | 0.120 |
Why?
|
| Gyrus Cinguli | 2 | 2018 | 1117 | 0.120 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 423 | 0.120 |
Why?
|
| Receptors, Vasopressin | 1 | 2015 | 106 | 0.120 |
Why?
|
| Epigenomics | 4 | 2022 | 959 | 0.120 |
Why?
|
| Absorptiometry, Photon | 5 | 2021 | 1707 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2019 | 565 | 0.120 |
Why?
|
| Prehypertension | 1 | 2015 | 63 | 0.120 |
Why?
|
| Heart Failure | 3 | 2015 | 11840 | 0.120 |
Why?
|
| Yoga | 1 | 2018 | 277 | 0.120 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2015 | 59 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2016 | 1192 | 0.120 |
Why?
|
| Orthodontics | 1 | 2015 | 77 | 0.120 |
Why?
|
| Diabetes Mellitus | 5 | 2021 | 5891 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2012 | 1402 | 0.120 |
Why?
|
| Nurses | 1 | 2024 | 2505 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3222 | 0.120 |
Why?
|
| Histone Deacetylase 1 | 1 | 2015 | 132 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2020 | 8923 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2023 | 1393 | 0.110 |
Why?
|
| Transcription Factors | 5 | 2020 | 12131 | 0.110 |
Why?
|
| Social Environment | 3 | 2021 | 1011 | 0.110 |
Why?
|
| Proprotein Convertase 2 | 1 | 2014 | 10 | 0.110 |
Why?
|
| Fuzzy Logic | 1 | 2014 | 58 | 0.110 |
Why?
|
| Genetic Research | 3 | 2013 | 173 | 0.110 |
Why?
|
| Leukocytes | 1 | 2022 | 2027 | 0.110 |
Why?
|
| England | 3 | 2024 | 533 | 0.110 |
Why?
|
| Arachidonic Acids | 1 | 2014 | 293 | 0.110 |
Why?
|
| Sickness Impact Profile | 1 | 2015 | 297 | 0.110 |
Why?
|
| Prognosis | 9 | 2019 | 29922 | 0.110 |
Why?
|
| Food | 1 | 2019 | 764 | 0.110 |
Why?
|
| Interviews as Topic | 3 | 2017 | 2739 | 0.110 |
Why?
|
| Lipase | 1 | 2016 | 320 | 0.110 |
Why?
|
| Putamen | 1 | 2015 | 289 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 4 | 2016 | 1612 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 1740 | 0.110 |
Why?
|
| Ion Transport | 1 | 2015 | 322 | 0.110 |
Why?
|
| Child Care | 1 | 2015 | 126 | 0.110 |
Why?
|
| Psychotropic Drugs | 2 | 2009 | 879 | 0.110 |
Why?
|
| West Indies | 1 | 2013 | 32 | 0.110 |
Why?
|
| Morocco | 1 | 2013 | 35 | 0.110 |
Why?
|
| Maternal-Fetal Relations | 2 | 2011 | 25 | 0.110 |
Why?
|
| Factor Analysis, Statistical | 2 | 2017 | 999 | 0.110 |
Why?
|
| Retrospective Studies | 14 | 2024 | 81514 | 0.110 |
Why?
|
| Urban Population | 2 | 2020 | 2040 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2020 | 838 | 0.110 |
Why?
|
| Bone Development | 1 | 2017 | 468 | 0.110 |
Why?
|
| Oral Health | 2 | 2018 | 493 | 0.110 |
Why?
|
| Finland | 3 | 2021 | 608 | 0.110 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2015 | 426 | 0.110 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 855 | 0.110 |
Why?
|
| Placentation | 1 | 2014 | 79 | 0.110 |
Why?
|
| Women's Health | 1 | 2023 | 2084 | 0.110 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 946 | 0.110 |
Why?
|
| Language Disorders | 1 | 2014 | 140 | 0.110 |
Why?
|
| Genes | 1 | 2017 | 1825 | 0.110 |
Why?
|
| Chromosome Disorders | 1 | 2016 | 498 | 0.110 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2013 | 140 | 0.110 |
Why?
|
| Brain Diseases | 2 | 2017 | 1546 | 0.110 |
Why?
|
| Birth Order | 1 | 2013 | 93 | 0.110 |
Why?
|
| Cross-Cultural Comparison | 1 | 2016 | 634 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2023 | 1263 | 0.110 |
Why?
|
| Eczema | 1 | 2016 | 246 | 0.110 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2015 | 246 | 0.100 |
Why?
|
| Arrhythmia, Sinus | 1 | 2012 | 48 | 0.100 |
Why?
|
| Lung | 2 | 2022 | 10033 | 0.100 |
Why?
|
| Gait | 2 | 2015 | 820 | 0.100 |
Why?
|
| Dyslexia | 1 | 2014 | 215 | 0.100 |
Why?
|
| Body Weights and Measures | 2 | 2010 | 208 | 0.100 |
Why?
|
| Turkey | 1 | 2013 | 281 | 0.100 |
Why?
|
| Genetic Linkage | 3 | 2017 | 2341 | 0.100 |
Why?
|
| Bottle Feeding | 1 | 2012 | 67 | 0.100 |
Why?
|
| Twins, Dizygotic | 1 | 2013 | 236 | 0.100 |
Why?
|
| Employment | 2 | 2009 | 1106 | 0.100 |
Why?
|
| Incidental Findings | 1 | 2017 | 697 | 0.100 |
Why?
|
| Forced Expiratory Volume | 4 | 2020 | 1828 | 0.100 |
Why?
|
| Body Image | 1 | 2017 | 644 | 0.100 |
Why?
|
| Attitude | 1 | 2017 | 770 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2013 | 271 | 0.100 |
Why?
|
| Pregnancy, High-Risk | 1 | 2012 | 121 | 0.100 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 687 | 0.100 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2017 | 521 | 0.100 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 254 | 0.100 |
Why?
|
| Suicide | 1 | 2023 | 1604 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2017 | 4913 | 0.100 |
Why?
|
| Mind-Body Therapies | 1 | 2015 | 294 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 9601 | 0.100 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2011 | 29 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 415 | 0.100 |
Why?
|
| Attitude to Death | 1 | 2015 | 399 | 0.100 |
Why?
|
| Pharmacoepidemiology | 3 | 2013 | 351 | 0.100 |
Why?
|
| Diabetic Neuropathies | 1 | 2015 | 408 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2017 | 1187 | 0.100 |
Why?
|
| Waist-Hip Ratio | 3 | 2019 | 520 | 0.090 |
Why?
|
| Restless Legs Syndrome | 1 | 2015 | 235 | 0.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2015 | 3247 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2017 | 978 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2011 | 88 | 0.090 |
Why?
|
| Vegetables | 1 | 2017 | 1199 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1385 | 0.090 |
Why?
|
| Triiodothyronine | 1 | 2013 | 496 | 0.090 |
Why?
|
| Vital Capacity | 3 | 2020 | 995 | 0.090 |
Why?
|
| Twins, Monozygotic | 1 | 2013 | 469 | 0.090 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 318 | 0.090 |
Why?
|
| Phobic Disorders | 1 | 2014 | 440 | 0.090 |
Why?
|
| Placenta Diseases | 1 | 2013 | 199 | 0.090 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 894 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2022 | 6255 | 0.090 |
Why?
|
| Adaptation, Psychological | 3 | 2018 | 2660 | 0.090 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2011 | 42 | 0.090 |
Why?
|
| Neoplasms | 7 | 2018 | 22340 | 0.090 |
Why?
|
| Receptors, Nicotinic | 2 | 2014 | 494 | 0.090 |
Why?
|
| Carbon | 1 | 2014 | 677 | 0.090 |
Why?
|
| Movement | 2 | 2008 | 1462 | 0.090 |
Why?
|
| Anesthetics | 1 | 2016 | 525 | 0.090 |
Why?
|
| Endocrine Disruptors | 1 | 2014 | 249 | 0.090 |
Why?
|
| Problem Solving | 1 | 2013 | 440 | 0.090 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 607 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 1394 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2016 | 959 | 0.090 |
Why?
|
| Mental Health Services | 1 | 2002 | 1723 | 0.090 |
Why?
|
| Psychological Tests | 4 | 2015 | 644 | 0.090 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 3432 | 0.090 |
Why?
|
| Genes, Homeobox | 1 | 2012 | 287 | 0.090 |
Why?
|
| Brain Infarction | 1 | 2012 | 285 | 0.090 |
Why?
|
| Beverages | 1 | 2016 | 819 | 0.090 |
Why?
|
| Leisure Activities | 1 | 2012 | 310 | 0.090 |
Why?
|
| Sports | 1 | 2017 | 698 | 0.090 |
Why?
|
| Dietary Fats | 2 | 2016 | 2002 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 854 | 0.090 |
Why?
|
| Somatosensory Cortex | 1 | 2014 | 510 | 0.090 |
Why?
|
| Consanguinity | 1 | 2012 | 460 | 0.090 |
Why?
|
| Drinking | 1 | 2011 | 196 | 0.090 |
Why?
|
| China | 3 | 2021 | 2385 | 0.090 |
Why?
|
| Psychology | 1 | 2012 | 354 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 412 | 0.090 |
Why?
|
| Home Childbirth | 1 | 2010 | 55 | 0.080 |
Why?
|
| Reinforcement, Verbal | 1 | 2009 | 3 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2014 | 704 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 1774 | 0.080 |
Why?
|
| Adipose Tissue | 2 | 2019 | 3312 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 1624 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2012 | 624 | 0.080 |
Why?
|
| Colic | 1 | 2009 | 42 | 0.080 |
Why?
|
| Mass Media | 1 | 2012 | 301 | 0.080 |
Why?
|
| Radio Waves | 2 | 2021 | 246 | 0.080 |
Why?
|
| Fever | 1 | 2017 | 1603 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1168 | 0.080 |
Why?
|
| Poverty Areas | 1 | 2011 | 268 | 0.080 |
Why?
|
| Blood Circulation | 1 | 2010 | 248 | 0.080 |
Why?
|
| Thinness | 1 | 2012 | 482 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2024 | 1043 | 0.080 |
Why?
|
| Mental Status Schedule | 3 | 2018 | 315 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2268 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 814 | 0.080 |
Why?
|
| Artifacts | 1 | 2017 | 1893 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 2648 | 0.080 |
Why?
|
| Dopamine | 1 | 2016 | 1582 | 0.080 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 246 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2002 | 1526 | 0.080 |
Why?
|
| Tacrolimus | 1 | 2012 | 753 | 0.080 |
Why?
|
| Encephalitis | 1 | 2012 | 441 | 0.080 |
Why?
|
| Immunoassay | 1 | 2012 | 741 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 735 | 0.080 |
Why?
|
| Electroencephalography | 2 | 2021 | 6273 | 0.080 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 532 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2009 | 108 | 0.080 |
Why?
|
| Cerebellar Cortex | 1 | 2009 | 108 | 0.080 |
Why?
|
| ROC Curve | 2 | 2017 | 3620 | 0.080 |
Why?
|
| Biomedical Research | 3 | 2023 | 3458 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2021 | 4618 | 0.080 |
Why?
|
| Femur Neck | 1 | 2010 | 316 | 0.080 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 12056 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3673 | 0.070 |
Why?
|
| Urban Health | 1 | 2011 | 530 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 791 | 0.070 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 1415 | 0.070 |
Why?
|
| Models, Theoretical | 3 | 2019 | 3564 | 0.070 |
Why?
|
| Epidemiology | 1 | 2010 | 279 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 10383 | 0.070 |
Why?
|
| Sudden Infant Death | 1 | 2011 | 292 | 0.070 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 669 | 0.070 |
Why?
|
| Analysis of Variance | 5 | 2016 | 6203 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2010 | 6832 | 0.070 |
Why?
|
| Obstetric Labor, Premature | 1 | 2009 | 268 | 0.070 |
Why?
|
| Serotonin | 3 | 2019 | 1049 | 0.070 |
Why?
|
| Growth | 1 | 2010 | 365 | 0.070 |
Why?
|
| Perception | 1 | 2014 | 1205 | 0.070 |
Why?
|
| Internet | 1 | 2020 | 3106 | 0.070 |
Why?
|
| Angiotensinogen | 1 | 2008 | 161 | 0.070 |
Why?
|
| Menarche | 1 | 2011 | 532 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2014 | 1187 | 0.070 |
Why?
|
| Dysthymic Disorder | 1 | 2008 | 73 | 0.070 |
Why?
|
| Respiratory Function Tests | 3 | 2018 | 1693 | 0.070 |
Why?
|
| Satiation | 2 | 2019 | 84 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1808 | 0.070 |
Why?
|
| Substance Abuse Detection | 1 | 2010 | 301 | 0.070 |
Why?
|
| Temperature | 2 | 2025 | 2226 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2021 | 3461 | 0.070 |
Why?
|
| Seafood | 1 | 2011 | 395 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 3607 | 0.070 |
Why?
|
| Albumins | 1 | 2010 | 577 | 0.070 |
Why?
|
| Probability | 2 | 2024 | 2475 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2172 | 0.070 |
Why?
|
| Norway | 2 | 2024 | 499 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2178 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 2334 | 0.070 |
Why?
|
| Cholesterol, LDL | 4 | 2023 | 2393 | 0.070 |
Why?
|
| Neural Tube Defects | 1 | 2009 | 256 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 1008 | 0.070 |
Why?
|
| Marriage | 1 | 2008 | 351 | 0.070 |
Why?
|
| Personality Inventory | 1 | 2009 | 1018 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1736 | 0.070 |
Why?
|
| Cardiovascular System | 1 | 2013 | 841 | 0.060 |
Why?
|
| Diet, Mediterranean | 1 | 2013 | 746 | 0.060 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 306 | 0.060 |
Why?
|
| Disease Progression | 4 | 2017 | 13632 | 0.060 |
Why?
|
| Appetite | 2 | 2019 | 247 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2015 | 6424 | 0.060 |
Why?
|
| Anger | 2 | 2023 | 402 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2014 | 1445 | 0.060 |
Why?
|
| Social Support | 1 | 2015 | 2192 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3985 | 0.060 |
Why?
|
| Pattern Recognition, Visual | 1 | 2011 | 820 | 0.060 |
Why?
|
| Pedigree | 3 | 2018 | 4526 | 0.060 |
Why?
|
| Particle Size | 2 | 2019 | 1631 | 0.060 |
Why?
|
| Endocrine System Diseases | 2 | 2009 | 243 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 1237 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 323 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2011 | 1069 | 0.060 |
Why?
|
| Alzheimer Disease | 7 | 2020 | 8730 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2015 | 3561 | 0.060 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2004 | 35 | 0.060 |
Why?
|
| Empathy | 1 | 2009 | 474 | 0.060 |
Why?
|
| Pediatrics | 2 | 2017 | 3606 | 0.060 |
Why?
|
| Morbidity | 2 | 2021 | 1749 | 0.060 |
Why?
|
| DNA Primers | 1 | 2009 | 2825 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2017 | 1732 | 0.060 |
Why?
|
| Animals | 9 | 2022 | 168764 | 0.060 |
Why?
|
| Heart | 1 | 2017 | 4414 | 0.060 |
Why?
|
| Mobility Limitation | 1 | 2008 | 408 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7851 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2004 | 240 | 0.050 |
Why?
|
| Pakistan | 1 | 2024 | 300 | 0.050 |
Why?
|
| Plasticizers | 1 | 2023 | 52 | 0.050 |
Why?
|
| Disabled Persons | 2 | 2009 | 1208 | 0.050 |
Why?
|
| Diet Surveys | 2 | 2017 | 1159 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4562 | 0.050 |
Why?
|
| Radiography | 2 | 2013 | 6919 | 0.050 |
Why?
|
| Canada | 2 | 2020 | 2119 | 0.050 |
Why?
|
| Terminal Care | 1 | 2015 | 1774 | 0.050 |
Why?
|
| World Health Organization | 1 | 2009 | 1328 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2008 | 855 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5125 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 2428 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 663 | 0.050 |
Why?
|
| Pre-Eclampsia | 2 | 2011 | 1261 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 3213 | 0.050 |
Why?
|
| Selection Bias | 1 | 2024 | 361 | 0.050 |
Why?
|
| Germany | 2 | 2017 | 882 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 386 | 0.050 |
Why?
|
| Extremities | 1 | 2007 | 869 | 0.050 |
Why?
|
| Cordocentesis | 1 | 2021 | 10 | 0.050 |
Why?
|
| Demography | 1 | 2006 | 1641 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2006 | 777 | 0.050 |
Why?
|
| Staff Development | 1 | 2023 | 230 | 0.050 |
Why?
|
| Suicide, Attempted | 2 | 2023 | 1409 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 65188 | 0.050 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.050 |
Why?
|
| Models, Structural | 1 | 2021 | 338 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2012 | 4184 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2014 | 3000 | 0.050 |
Why?
|
| Nutrition Assessment | 2 | 2016 | 738 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5370 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 7425 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2008 | 2033 | 0.050 |
Why?
|
| Paternal Exposure | 2 | 2013 | 101 | 0.050 |
Why?
|
| Exons | 2 | 2017 | 2391 | 0.040 |
Why?
|
| Americas | 1 | 2020 | 109 | 0.040 |
Why?
|
| Retirement | 1 | 2022 | 198 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3251 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2006 | 1591 | 0.040 |
Why?
|
| Education | 2 | 2017 | 533 | 0.040 |
Why?
|
| Palliative Care | 1 | 2015 | 3645 | 0.040 |
Why?
|
| Kidney | 1 | 2015 | 7066 | 0.040 |
Why?
|
| Developing Countries | 1 | 2013 | 2911 | 0.040 |
Why?
|
| Suicidal Ideation | 2 | 2023 | 1461 | 0.040 |
Why?
|
| Recurrence | 2 | 2012 | 8501 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2024 | 794 | 0.040 |
Why?
|
| Echocardiography | 1 | 2013 | 5045 | 0.040 |
Why?
|
| Models, Biological | 1 | 2016 | 9443 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2023 | 1180 | 0.040 |
Why?
|
| European Union | 1 | 2021 | 157 | 0.040 |
Why?
|
| Population Density | 1 | 2020 | 193 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2004 | 1689 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 4209 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 200 | 0.040 |
Why?
|
| Sunburn | 1 | 2020 | 156 | 0.040 |
Why?
|
| Noise | 1 | 2021 | 296 | 0.040 |
Why?
|
| Nucleotides | 1 | 2021 | 451 | 0.040 |
Why?
|
| Health Status Indicators | 2 | 2017 | 966 | 0.040 |
Why?
|
| Heterozygote | 2 | 2016 | 2794 | 0.040 |
Why?
|
| Algorithms | 3 | 2017 | 14071 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1167 | 0.040 |
Why?
|
| alpha-Linolenic Acid | 1 | 2019 | 145 | 0.040 |
Why?
|
| Databases, Factual | 4 | 2017 | 8067 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2018 | 113 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2020 | 245 | 0.040 |
Why?
|
| Climate Change | 1 | 2025 | 509 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2018 | 101 | 0.040 |
Why?
|
| Mutation | 4 | 2018 | 30198 | 0.040 |
Why?
|
| Boredom | 1 | 2017 | 6 | 0.040 |
Why?
|
| Base Sequence | 1 | 2009 | 12403 | 0.040 |
Why?
|
| Urbanization | 1 | 2018 | 101 | 0.040 |
Why?
|
| Specialization | 1 | 2002 | 777 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 660 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2006 | 2267 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2022 | 970 | 0.040 |
Why?
|
| Colombia | 1 | 2018 | 287 | 0.040 |
Why?
|
| Belgium | 1 | 2017 | 119 | 0.040 |
Why?
|
| RGS Proteins | 1 | 2017 | 75 | 0.030 |
Why?
|
| Socialization | 1 | 2017 | 87 | 0.030 |
Why?
|
| Feces | 1 | 2024 | 1504 | 0.030 |
Why?
|
| Poland | 1 | 2017 | 195 | 0.030 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2016 | 67 | 0.030 |
Why?
|
| Pongo | 1 | 2016 | 4 | 0.030 |
Why?
|
| alpha-Mannosidase | 1 | 2016 | 19 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12437 | 0.030 |
Why?
|
| Environmental Pollution | 1 | 2018 | 125 | 0.030 |
Why?
|
| Ethanol | 2 | 2015 | 1323 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2006 | 1921 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 130 | 0.030 |
Why?
|
| Ethinyl Estradiol | 1 | 2017 | 111 | 0.030 |
Why?
|
| Weather | 1 | 2018 | 234 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 879 | 0.030 |
Why?
|
| Japan | 1 | 2020 | 1415 | 0.030 |
Why?
|
| Glycerophospholipids | 1 | 2016 | 39 | 0.030 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 65 | 0.030 |
Why?
|
| Esthetics, Dental | 1 | 2018 | 267 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2016 | 81 | 0.030 |
Why?
|
| Mental Processes | 1 | 2017 | 243 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 246 | 0.030 |
Why?
|
| Contraceptive Agents, Female | 1 | 2017 | 123 | 0.030 |
Why?
|
| Intrauterine Devices | 1 | 2017 | 115 | 0.030 |
Why?
|
| Dental Care | 1 | 2018 | 286 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2002 | 2424 | 0.030 |
Why?
|
| Italy | 1 | 2017 | 854 | 0.030 |
Why?
|
| Iceland | 1 | 2015 | 183 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2017 | 616 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2023 | 2499 | 0.030 |
Why?
|
| Health Services Research | 1 | 2002 | 1808 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2016 | 360 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 353 | 0.030 |
Why?
|
| Octamer Transcription Factors | 1 | 2014 | 18 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2018 | 705 | 0.030 |
Why?
|
| Nonverbal Communication | 1 | 2015 | 63 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2019 | 1467 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 798 | 0.030 |
Why?
|
| Kallikreins | 1 | 2016 | 220 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2018 | 793 | 0.030 |
Why?
|
| Fasting | 1 | 2021 | 1606 | 0.030 |
Why?
|
| Antioxidants | 1 | 2002 | 1670 | 0.030 |
Why?
|
| Delirium | 1 | 2006 | 1707 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 2014 | 91 | 0.030 |
Why?
|
| Potassium Channels | 1 | 2017 | 534 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2010 | 605 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 381 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2014 | 122 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 472 | 0.030 |
Why?
|
| Ethiopia | 1 | 2016 | 485 | 0.030 |
Why?
|
| Medicine | 1 | 2002 | 942 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2016 | 217 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2014 | 139 | 0.030 |
Why?
|
| Motion | 1 | 2017 | 781 | 0.030 |
Why?
|
| Iodides | 1 | 2013 | 39 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1339 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2018 | 542 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 523 | 0.030 |
Why?
|
| Nutritive Value | 1 | 2016 | 351 | 0.030 |
Why?
|
| Alcoholic Beverages | 1 | 2015 | 265 | 0.030 |
Why?
|
| Personality | 1 | 2017 | 560 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 683 | 0.030 |
Why?
|
| Nutrition Policy | 1 | 2017 | 467 | 0.030 |
Why?
|
| Umbilical Arteries | 1 | 2013 | 78 | 0.030 |
Why?
|
| Atrophy | 1 | 2018 | 1635 | 0.030 |
Why?
|
| Coronary Artery Disease | 2 | 2010 | 6544 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2002 | 1645 | 0.030 |
Why?
|
| Iron | 1 | 2021 | 1816 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1180 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 350 | 0.030 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2014 | 262 | 0.030 |
Why?
|
| Motivation | 2 | 2017 | 2018 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 260 | 0.030 |
Why?
|
| Cohort Effect | 1 | 2012 | 39 | 0.030 |
Why?
|
| Corticosterone | 1 | 2013 | 301 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 3690 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2018 | 810 | 0.030 |
Why?
|
| Concept Formation | 1 | 2013 | 159 | 0.020 |
Why?
|
| Solubility | 1 | 2014 | 1078 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2013 | 137 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2018 | 1481 | 0.020 |
Why?
|
| Metabolome | 1 | 2019 | 1005 | 0.020 |
Why?
|
| Antigens | 1 | 2018 | 1438 | 0.020 |
Why?
|
| Spirometry | 1 | 2015 | 929 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2018 | 1138 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 990 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 323 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2017 | 1158 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2013 | 326 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1880 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2018 | 866 | 0.020 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2011 | 43 | 0.020 |
Why?
|
| Phospholipids | 1 | 2015 | 776 | 0.020 |
Why?
|
| Brazil | 1 | 2015 | 1248 | 0.020 |
Why?
|
| Mice | 4 | 2017 | 81819 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2002 | 3141 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2015 | 604 | 0.020 |
Why?
|
| Hand Strength | 1 | 2014 | 462 | 0.020 |
Why?
|
| Endophenotypes | 1 | 2013 | 258 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2014 | 413 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 2017 | 709 | 0.020 |
Why?
|
| Child Health Services | 1 | 2016 | 645 | 0.020 |
Why?
|
| Stroop Test | 1 | 2011 | 71 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2009 | 4628 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14652 | 0.020 |
Why?
|
| Tritium | 1 | 2011 | 702 | 0.020 |
Why?
|
| Food, Fortified | 1 | 2012 | 189 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1024 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 623 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1589 | 0.020 |
Why?
|
| Maternal-Child Health Centers | 1 | 2010 | 41 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2017 | 2077 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 3797 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 605 | 0.020 |
Why?
|
| Population | 1 | 2011 | 140 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2016 | 511 | 0.020 |
Why?
|
| Genome | 1 | 2018 | 1753 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 941 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2798 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2011 | 103 | 0.020 |
Why?
|
| Gene Expression | 2 | 2014 | 7584 | 0.020 |
Why?
|
| Micronutrients | 1 | 2013 | 390 | 0.020 |
Why?
|
| Cleft Palate | 1 | 2016 | 591 | 0.020 |
Why?
|
| Axons | 1 | 2018 | 1682 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2505 | 0.020 |
Why?
|
| Parkinson Disease | 2 | 2016 | 2895 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2005 | 14448 | 0.020 |
Why?
|
| Software | 2 | 2015 | 4462 | 0.020 |
Why?
|
| Prone Position | 1 | 2011 | 201 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9525 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 430 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 1077 | 0.020 |
Why?
|
| Protein Binding | 2 | 2014 | 9296 | 0.020 |
Why?
|
| Lod Score | 1 | 2010 | 598 | 0.020 |
Why?
|
| Uterus | 1 | 2013 | 661 | 0.020 |
Why?
|
| Counseling | 1 | 2017 | 1551 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2341 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2011 | 328 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1072 | 0.020 |
Why?
|
| Child Welfare | 1 | 2013 | 521 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2018 | 2020 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2008 | 5189 | 0.020 |
Why?
|
| Central Nervous System Depressants | 1 | 2010 | 163 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2013 | 742 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2011 | 471 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 2008 | 30 | 0.020 |
Why?
|
| Medical Audit | 1 | 2010 | 452 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2009 | 227 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3584 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1375 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9338 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3336 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2016 | 2354 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2014 | 844 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Threonine | 1 | 2008 | 272 | 0.020 |
Why?
|
| Nervous System Diseases | 2 | 2009 | 1660 | 0.020 |
Why?
|
| Antibodies | 1 | 2015 | 2417 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20659 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2878 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2980 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2589 | 0.020 |
Why?
|
| Diuretics | 1 | 2010 | 613 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 2006 | 73 | 0.020 |
Why?
|
| Syndrome | 1 | 2013 | 3271 | 0.020 |
Why?
|
| Caffeine | 1 | 2011 | 702 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 952 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2006 | 94 | 0.020 |
Why?
|
| Genomics | 2 | 2014 | 5929 | 0.020 |
Why?
|
| Prisoners | 1 | 2009 | 316 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 1151 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3835 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1883 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10429 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 569 | 0.020 |
Why?
|
| Cities | 1 | 2008 | 543 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2017 | 2517 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2011 | 704 | 0.020 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2006 | 137 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1751 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4772 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 2932 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8529 | 0.020 |
Why?
|
| Pancrelipase | 1 | 2004 | 7 | 0.010 |
Why?
|
| Liver | 1 | 2021 | 7562 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3475 | 0.010 |
Why?
|
| Parietal Cells, Gastric | 1 | 2004 | 39 | 0.010 |
Why?
|
| Religion | 1 | 2008 | 376 | 0.010 |
Why?
|
| Gastritis, Atrophic | 1 | 2004 | 31 | 0.010 |
Why?
|
| Memory | 1 | 2014 | 2190 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3596 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2910 | 0.010 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 708 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5526 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2900 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3559 | 0.010 |
Why?
|
| Dyspnea | 1 | 2012 | 1352 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2017 | 3242 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 2002 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2009 | 659 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 561 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2013 | 2692 | 0.010 |
Why?
|
| Weight Loss | 1 | 2014 | 2710 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2453 | 0.010 |
Why?
|
| Health Education | 1 | 2008 | 1060 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2009 | 1624 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3672 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10261 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 5786 | 0.010 |
Why?
|
| Alcoholism | 1 | 2011 | 1975 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2006 | 729 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 1709 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2009 | 1303 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11641 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 23707 | 0.010 |
Why?
|
| Cytokines | 1 | 2015 | 7421 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2004 | 1965 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2006 | 861 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9525 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7599 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15543 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 2721 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 9071 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 12768 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18293 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 23601 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13451 | 0.000 |
Why?
|